These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa. Kana BD; Arbuthnot P; Botwe BK; Choonara YE; Hassan F; Louzir H; Matsoso P; Moore PL; Muhairwe A; Naidoo K; Ndomondo-Sigonda M; Madhi SA Lancet Infect Dis; 2023 Aug; 23(8):e288-e300. PubMed ID: 37290473 [TBL] [Abstract][Full Text] [Related]
3. Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives. Saied AA; Metwally AA; Dhawan M; Choudhary OP; Aiash H EMBO Mol Med; 2022 Aug; 14(8):e16287. PubMed ID: 35758210 [TBL] [Abstract][Full Text] [Related]
4. Advancing Vaccinology Capacity: Education and Efforts in Vaccine Development and Manufacturing across Africa. Sinumvayo JP; Munezero PC; Tope AT; Adeyemo RO; Bale MI; Nyandwi JB; Haakuria VM; Mutesa L; Adedeji AA Vaccines (Basel); 2024 Jul; 12(7):. PubMed ID: 39066380 [TBL] [Abstract][Full Text] [Related]
5. Rural communities in Africa should not be forgotten in responses to COVID-19. Ogunkola IO; Adebisi YA; Imo UF; Odey GO; Esu E; Lucero-Prisno DE Int J Health Plann Manage; 2020 Nov; 35(6):1302-1305. PubMed ID: 32790138 [TBL] [Abstract][Full Text] [Related]
6. Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa. Margolin E; Burgers WA; Sturrock ED; Mendelson M; Chapman R; Douglass N; Williamson AL; Rybicki EP Nat Rev Microbiol; 2020 Dec; 18(12):690-704. PubMed ID: 32913297 [TBL] [Abstract][Full Text] [Related]
7. Advocating for efforts to protect African children, families, and communities from the threat of infectious diseases: report of the First International African Vaccinology Conference. Wiysonge CS; Waggie Z; Hawkridge A; Schoub B; Madhi SA; Rees H; Hussey G Pan Afr Med J; 2016; 23():53. PubMed ID: 27217879 [TBL] [Abstract][Full Text] [Related]
8. Equal access of COVID-19 vaccine distribution in Africa: Challenges and way forward. Aborode AT; Olofinsao OA; Osmond E; Batubo AP; Fayemiro O; Sherifdeen O; Muraina L; Obadawo BS; Ahmad S; Fajemisin EA J Med Virol; 2021 Sep; 93(9):5212-5215. PubMed ID: 34009657 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa. Bright B; Babalola CP; Sam-Agudu NA; Onyeaghala AA; Olatunji A; Aduh U; Sobande PO; Crowell TA; Tebeje YK; Phillip S; Ndembi N; Folayan MO Global Health; 2021 Mar; 17(1):24. PubMed ID: 33658050 [TBL] [Abstract][Full Text] [Related]
10. Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward. Lawal L; Aminu Bello M; Murwira T; Avoka C; Yusuf Ma'aruf S; Harrison Omonhinmin I; Maluleke P; Tsagkaris C; Onyeaka H Hum Vaccin Immunother; 2022 Dec; 18(1):2034457. PubMed ID: 35240908 [TBL] [Abstract][Full Text] [Related]
11. Implementation of Public Health Genomics in Africa: Lessons from the COVID-19 pandemic, challenges, and recommendations. Moyo E; Moyo P; Mashe T; Dzobo M; Chitungo I; Dzinamarira T J Med Virol; 2023 Jan; 95(1):e28295. PubMed ID: 36366938 [TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccines and vaccination: how prepared is Africa? Ariyo OE; Oladipo EK; Osasona OG; Obe O; Olomojobi F Pan Afr Med J; 2021; 39():107. PubMed ID: 34512843 [TBL] [Abstract][Full Text] [Related]
13. Factors, enablers and challenges for COVID-19 vaccine development. Excler JL; Saville M; Privor-Dumm L; Gilbert S; Hotez PJ; Thompson D; Abdool-Karim S; Kim JH BMJ Glob Health; 2023 Jun; 8(6):. PubMed ID: 37277195 [TBL] [Abstract][Full Text] [Related]
14. Building global vaccine manufacturing capacity: Spotlight on Africa. Rubin Thompson LJ; Grubo M; Veller M; Badenhorst RH; Nott J; Debruyne L; Makadzange T; Nicolaou S; Stanberry L; Sall A; James WG Vaccine; 2023 Jun; 41(27):4050-4056. PubMed ID: 37173266 [TBL] [Abstract][Full Text] [Related]
15. Who Will Pay for the COVID-19 Vaccines for Africa? Lucero-Prisno DE; Ogunkola IO; Imo UF; Adebisi YA Am J Trop Med Hyg; 2021 Jan; 104(3):794-796. PubMed ID: 33427194 [TBL] [Abstract][Full Text] [Related]
16. Advanced vaccinology training globally: Update and impact of the COVID-19 crisis. Dochez C; Duclos P; MacDonald N; Steffen C; Lambert PH; Vaccine; 2022 Sep; 40(39):5683-5690. PubMed ID: 36030127 [TBL] [Abstract][Full Text] [Related]
17. Vaccinology in the post-COVID-19 era. Rappuoli R; De Gregorio E; Del Giudice G; Phogat S; Pecetta S; Pizza M; Hanon E Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33431690 [TBL] [Abstract][Full Text] [Related]
18. The experience of disproportionate supplies of COVID-19 vaccines to Africa: the need for Africa to decolonize its public health response. Adeoye AO; Okunola JL; Fakunle SO Pan Afr Med J; 2023; 44():54. PubMed ID: 37128613 [TBL] [Abstract][Full Text] [Related]
19. Delayed Access to COVID-19 Vaccines: A Perspective on Low-income Countries in Africa. Hassan MA; Aliyu S Int J Health Serv; 2022 Jul; 52(3):323-329. PubMed ID: 35469499 [TBL] [Abstract][Full Text] [Related]
20. Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study. Grenfell RFQ; Oyeyemi OT Pathog Glob Health; 2023 Mar; 117(2):152-166. PubMed ID: 35770309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]